Antifungal • Triazole class

Buy Voriconazole Online – Trusted Antifungal Medication

Voriconazole is a potent antifungal treatment used for serious fungal infections including aspergillosis and candidemia.

Buy Voriconazole Now →
▼ Table of Contents

Voriconazole Overview

Voriconazole is a second‑generation triazole antifungal medication widely used in modern clinical practice for the treatment of severe, life‑threatening fungal infections. It is considered the first‑line therapy for invasive aspergillosis and is frequently used in immunocompromised patients, including those undergoing chemotherapy, organ transplantation, or long‑term corticosteroid therapy.

One of the defining characteristics of Voriconazole is its ability to penetrate deeply into tissues, including the lungs, bloodstream, and central nervous system. This makes it particularly valuable in cases where fungal infections spread beyond their initial site. Because of its strong clinical performance and predictable pharmacokinetics, Voriconazole has become a cornerstone antifungal in hospital settings worldwide.

Voriconazole

What is Voriconazole?

Voriconazole is a triazole antifungal medication used to treat severe fungal infections. It works by inhibiting the fungal cytochrome P450–dependent enzyme 14‑α‑demethylase, which is essential for the synthesis of ergosterol — a key structural component of fungal cell membranes.

Clinically, Voriconazole is used to treat a wide range of fungal infections, including invasive aspergillosis, candidemia, esophageal candidiasis, and infections caused by Scedosporium and Fusarium species. These infections are often difficult to treat and may be fatal without aggressive antifungal therapy.

Because of its broad spectrum and strong clinical evidence, Voriconazole is considered one of the most trusted antifungal agents available today.

Quick Facts

  • Second‑generation triazole antifungal
  • First‑line treatment for invasive aspergillosis
  • Effective against resistant molds
  • Available in oral and IV formulations

Key Benefits of Voriconazole

Voriconazole offers several clinical advantages that make it a preferred antifungal in critical care and oncology settings. Its broad spectrum, strong clinical evidence, and flexible dosing options allow physicians to treat complex fungal infections with confidence.

Broad Spectrum

Effective against Aspergillus, Candida, Scedosporium, Fusarium, and other resistant molds.

High Tissue Penetration

Reaches therapeutic levels in lungs, bloodstream, and CNS — essential for severe infections.

Strong Clinical Evidence

Supported by numerous trials demonstrating superior outcomes in invasive aspergillosis.

How Voriconazole Works

Voriconazole inhibits fungal cytochrome P450 enzymes, blocking the synthesis of ergosterol — a vital component of fungal cell membranes. Without ergosterol, the membrane becomes unstable, leading to impaired growth and eventual fungal cell death.

The drug demonstrates fungicidal activity against Aspergillus species and fungistatic activity against Candida species. It is also effective against many molds that are resistant to amphotericin B or fluconazole, making it a critical option for patients with refractory infections.

Voriconazole’s ability to achieve high concentrations in tissues and its predictable pharmacodynamics make it particularly effective in severe systemic infections.

Mechanism Summary

  • Blocks ergosterol synthesis
  • Disrupts fungal cell membranes
  • Highly selective for fungal enzymes
  • Effective against resistant molds

Clinical Use Cases

Voriconazole is primarily used in severe fungal infections where rapid and effective antifungal therapy is essential. It is especially valuable in immunocompromised patients.

Voriconazole Dosages

Strength Form Use
50 mg Tablet Maintenance dosing
200 mg Tablet Standard adult dosing
IV formulation Injection Severe infections

Pharmacokinetics

Voriconazole exhibits nonlinear pharmacokinetics, meaning that small changes in dose can lead to disproportionately large changes in blood concentration. This is why therapeutic drug monitoring (TDM) is often recommended.

The drug is metabolized primarily in the liver via CYP2C19, CYP2C9, and CYP3A4 pathways. Genetic variations in CYP2C19 can significantly affect drug levels, making individualized dosing important in some cases.

Voriconazole also has excellent oral bioavailability, allowing patients to transition from IV to oral therapy without loss of efficacy.

How to Take Voriconazole

  • Take at least 1 hour before or after meals.
  • Follow exact dosing prescribed by your doctor.
  • Do not skip doses — consistency is critical.
  • Therapeutic drug monitoring may be required.

Important Notes

  • Avoid sunlight exposure.
  • Monitor liver function regularly.
  • Do not mix with certain medications.

Who Voriconazole Is For

  • Patients with invasive aspergillosis
  • Patients with candidemia
  • Immunocompromised individuals

Who Should NOT Use

  • People with severe liver disease
  • Patients taking contraindicated medications
  • Pregnant women unless essential

Drug Interactions

  • Rifampin
  • Carbamazepine
  • Warfarin
  • Statins

Contraindications

  • Known hypersensitivity
  • Severe hepatic impairment
  • Concurrent CYP450 inducers

Warnings

  • May cause visual disturbances.
  • Photosensitivity reactions possible.
  • Monitor liver enzymes regularly.

Common Side Effects

  • Visual changes
  • Nausea
  • Headache
  • Skin rash

Rare Side Effects

  • Liver toxicity
  • Hallucinations
  • Severe skin reactions

Voriconazole Compared to Other Antifungals

Voriconazole is often compared with other antifungal agents due to its broad spectrum, strong clinical evidence, and role as a first‑line therapy for invasive aspergillosis. Below is a detailed comparison with the most commonly used antifungals.

Voriconazole vs Fluconazole

Spectrum: Fluconazole is effective mainly against Candida species, while Voriconazole covers Candida plus Aspergillus and many resistant molds.

Use cases: Fluconazole is used for mucosal candidiasis and mild systemic infections. Voriconazole is used for invasive aspergillosis, candidemia, and resistant fungal infections.

Resistance: Fluconazole resistance is increasingly common. Voriconazole remains effective against many fluconazole‑resistant strains.

When Voriconazole is preferred: Severe infections, mold infections, immunocompromised patients.

When Fluconazole is preferred: Mild Candida infections, lower cost, fewer side effects.

Voriconazole vs Amphotericin B

Potency: Amphotericin B is extremely potent and fungicidal, but highly toxic. Voriconazole is potent but significantly safer.

Toxicity: Amphotericin B causes nephrotoxicity, electrolyte imbalance, and infusion reactions. Voriconazole has fewer systemic toxicities.

Use cases: Amphotericin B is used for severe, rapidly progressing infections. Voriconazole is first‑line for invasive aspergillosis.

When Voriconazole is preferred: Aspergillus infections, long‑term therapy, patients with kidney issues.

When Amphotericin B is preferred: Life‑threatening infections requiring immediate fungicidal action.

Voriconazole vs Itraconazole

Spectrum: Both cover Aspergillus, but Voriconazole is more potent and reliable.

Absorption: Itraconazole absorption varies with food and stomach acidity; Voriconazole has more predictable pharmacokinetics.

Use cases: Itraconazole is used for chronic pulmonary aspergillosis and histoplasmosis. Voriconazole is used for invasive aspergillosis and severe systemic infections.

When Voriconazole is preferred: Acute, invasive, or rapidly progressing fungal infections.

When Itraconazole is preferred: Long‑term maintenance therapy for chronic fungal diseases.

Voriconazole vs Posaconazole

Spectrum: Posaconazole covers Mucorales (mucormycosis), which Voriconazole does not.

Use cases: Posaconazole is used for prophylaxis in high‑risk patients and mucormycosis. Voriconazole is used for invasive aspergillosis.

Pharmacokinetics: Posaconazole requires food for optimal absorption; Voriconazole does not.

When Voriconazole is preferred: Aspergillus infections, Candida bloodstream infections.

When Posaconazole is preferred: Mucormycosis, prophylaxis in leukemia or transplant patients.

Voriconazole vs Isavuconazole

Tolerability: Isavuconazole has fewer side effects and no QT prolongation risk.

Spectrum: Both cover Aspergillus; Isavuconazole also covers Mucorales.

Use cases: Isavuconazole is used for mucormycosis and invasive aspergillosis. Voriconazole is first‑line for aspergillosis.

When Voriconazole is preferred: Proven Aspergillus infections with need for rapid response.

When Isavuconazole is preferred: Patients with cardiac risk factors or QT prolongation.

Voriconazole vs Caspofungin

Class: Caspofungin is an echinocandin; Voriconazole is a triazole.

Spectrum: Caspofungin is excellent for Candida but weak against Aspergillus. Voriconazole is strong against both.

Use cases: Caspofungin is used for candidemia and salvage therapy. Voriconazole is used for invasive aspergillosis.

When Voriconazole is preferred: Mold infections, especially Aspergillus.

When Caspofungin is preferred: Severe Candida infections, especially in unstable patients.

Voriconazole Pricing

Voriconazole is available in multiple strengths and formulations. Prices vary depending on dosage and quantity.

Strength Form Quantity Price
50 mg Tablet 4 tablets $89.00
50 mg Tablet 8 tablets $159.00
50 mg Tablet 12 tablets $219.00
200 mg Tablet 4 tablets $169.00
200 mg Tablet 8 tablets $299.00
200 mg Tablet 12 tablets $419.00
200 mg IV Vial 1 vial $189.00
200 mg IV Vial 2 vials $349.00

Secure the Best Voriconazole Price

Fast Shipping Worldwide Delivery High Quality Guaranteed Secure Payments

Partner prices update daily — lock in today’s lowest offer before stock or rates change. No hidden fees, no middlemen, full transparency.

Check Voriconazole Cost →

Voriconazole – Frequently Asked Questions

Voriconazole is used to treat severe fungal infections such as invasive aspergillosis, candidemia, and infections caused by resistant molds.

It inhibits fungal cytochrome P450 enzymes, blocking ergosterol synthesis and destabilizing fungal cell membranes.

Clinical improvement may begin within 48–72 hours, depending on infection severity and immune status.

It should be taken at least 1 hour before or after meals to ensure optimal absorption.

Common side effects include visual disturbances, nausea, headache, and skin sensitivity to sunlight.

Yes, temporary visual changes such as blurred vision or altered color perception may occur, especially early in treatment.

Long-term use is possible but requires liver monitoring and periodic blood level checks (TDM).

Yes, it interacts with many drugs metabolized by CYP450 enzymes, including warfarin, statins, and anticonvulsants.

Dose adjustments may be required; liver function should be monitored regularly.

Yes, but dosing differs from adults and requires specialist supervision.

Voriconazole covers Aspergillus and resistant molds, while Fluconazole mainly treats Candida. Voriconazole is preferred for severe systemic infections.

Amphotericin B is more potent but significantly more toxic. Voriconazole is safer for long-term therapy.

Voriconazole is more potent and reliable for invasive infections; Itraconazole is used for chronic fungal diseases.

Posaconazole covers Mucorales; Voriconazole does not. Voriconazole is preferred for Aspergillus infections.

Isavuconazole has fewer side effects and no QT prolongation risk, but Voriconazole remains first‑line for aspergillosis in many guidelines.

Yes, patients should avoid direct sunlight and use sun protection during treatment.

Alcohol increases liver strain and should be avoided during Voriconazole therapy.

Take it as soon as possible unless it is close to the next dose. Do not double dose.

Treatment duration varies from weeks to months depending on infection severity and immune status.

Alternative antifungals such as Amphotericin B, Posaconazole, or Isavuconazole may be required under specialist guidance.